Abstract
Purpose
Several reports have shown a better prognosis in gastric cancer patients who are positive for Helicobacter pylori (HP) infection compared with negative cases. However, there are currently no studies that investigate the relationship between HP infection and the effects of chemotherapy in gastric cancer patients. In this study, we report the relationship between HP infection and chemotherapy effects in patients with advanced or metastatic gastric cancer.
Methods
Sixty-one patients with advanced or metastatic gastric cancer were enrolled in this study. Biopsies were conducted around the tumor site to determine HP status. Patients were then treated with combination 5-FU and cisplatin-based chemotherapy. And we compared chemotherapy response rate and overall survival rate between HP infection group and without HP infection group.
Results
Twelve of 18 patients with HP infection (66.7 %) and 9 of 42 patients without HP infection (21.4 %) showed a partial response to chemotherapy (Chi square P = 0.001). Patients with HP infection had a median survival time of 13 months (95 % CI, 6.9–19.1 months), which was significantly longer than that of patients without HP infection (9 months; P = 0.027, log-rank test).
Conclusions
Patients with advanced or metastatic gastric cancer with concomitant HP infection had a better response to chemotherapy and had an improved overall prognosis compared with patients without HP infection. Further studies are warranted to confirm these findings.
Similar content being viewed by others
References
Nomura AM, Kolonel LN, Miki K et al (2005) Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii. J Infect Dis 191:2075–2081
Meimarakis G, Winter H, Assmann I et al (2006) Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol 7:211–222
Marrelli D, Pedrazzani C, Berardi A et al (2009) Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer 115:2071–2080
Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 20:1161–1181
Stadtlander CT, Waterbor JW (1999) Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 20:2195–2208
Hansson LE, Engstrand L, Nyren O et al (1993) Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 105:1098–1103
Chow WH, Blaser MJ, Blot WJ et al (1998) An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 58:588–590
Ohno S, Tomisaki S, Oiwa H et al (1995) Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 180:577–582
Helicobacter and Cancer Collaboration Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347–353
Malaty HM, Kim JG, Kim SD, Graham DY (1996) Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. Am J Epidemiol 143:257–262
Lee HJ, Yang HK, Ahn YO (2002) Gastric cancer in Korea. Gastric Cancer 5:177–182
Kohli Y, Tanaka Y, Kato T, Ito S (1993) Endoscopic diagnosis of Helicobacter pylori distribution in human gastric mucosa by phenol red dye spraying method. Nihon Rinsho 51:3182–3186
Iseki K, Tatsuta M, Iishi H, Baba M, Ishiguro S (1998) Helicobacter pylori infection in patients with early gastric cancer by the endoscopic phenol red test. Gut 42:20–23
Araujo-Filho I, Brandao-Neto J, Pinheiro LA, Azevedo IM, Freire FH, Medeiros AC (2006) Prevalence of Helicobacter pylori infection in advanced gastric carcinoma. Arq Gastroenterol 43:288–292
Caruso ML, Fucci L (1990) Histological identification of Helicobacter pylori in early and advanced gastric cancer. J Clin Gastroenterol 12:601–602
Tang YL, Gan RL, Dong BH, Jiang RC, Tang RJ (2005) Detection and location of Helicobacter pylori in human gastric carcinomas. World J Gastroenterol 11:1387–1391
Hobsley M, Tovey FI, Holton J (2007) Helicobacter pylori and gastric cancer: neither friend nor foe. Gastroenterology 132:2076
Qiu HB, Zhang LY, Keshari RP et al (2010) Relationship between H. pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer 10:374
Kang SY, Han JH, Ahn MS et al. (2012) Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection. Int J Cancer 130:948–958
Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269
Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM (2001) Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 125:1–9
Acknowledgments
This study was supported by a Korea University Grant.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, I.K., Sung, H.J., Lee, JH. et al. The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer. Cancer Chemother Pharmacol 70, 555–558 (2012). https://doi.org/10.1007/s00280-012-1944-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-012-1944-5